The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to wave application and evaluation fees, as well as expediting its assessment […]
Australia expedites review of medical cannabis product Epidiolex is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs